Human natural killer INK) cells are large granular lymphocytes that constitutively express functional forms of the interleukin-2 receptor (IL-2R) and lyse tumor and virally infected cells without prior sensitization. NK cells with high density expression of CD56 (CD56b'ieh') express the high affinity IL-2R and proliferate in response t o l o w (picomolar) concentrations of IL-2. CD56d'm NK cells express the intermediate affinity IL-2R and demonstrate enhanced cytotoxic activity without proliferation in response t o high (nanomolar) concentrations of IL-2. In the present study, we characterized IL-1OR expression on human NK cells and the functional consequences of IL-10 binding directly t o highly purified subsets of CD56b"ght and CD56dim NK cells. Binding studies using lZ5l-IL-10 indicated that resting human NK cells constitutively express the IL-10 receptor protein at a surface density of approximately 90 receptor sites per cell, with a kd of -1 nmol/L. Alone, IL-10 did not induce proliferation of CD56b'igh' or CD56dim NK cell subsets. However, at low concentrations (0.5 t o 5 ng/mL), IL-10 significantly augmented IL-2-induced
Human natural killer INK) cells are large granular lymphocytes that constitutively express functional forms of the interleukin-2 receptor (IL-2R) and lyse tumor and virally infected cells without prior sensitization. NK cells with high density expression of CD56 (CD56b'ieh') express the high affinity IL-2R and proliferate in response t o l o w (picomolar) concentrations of IL-2. CD56d'm NK cells express the intermediate affinity IL-2R and demonstrate enhanced cytotoxic activity without proliferation in response t o high (nanomolar) concentrations of IL-2. In the present study, we characterized IL-1OR expression on human NK cells and the functional consequences of IL-10 binding directly t o highly purified subsets of CD56b"ght and CD56dim NK cells. Binding studies using lZ5l-IL-10 indicated that resting human NK cells constitutively express the IL-10 receptor protein at a surface density of approximately 90 receptor sites per cell, with a kd of -1 nmol/L. Alone, IL-10 did not induce proliferation of CD56b'igh' or CD56dim NK cell subsets. However, at low concentrations (0.5 t o 5 ng/mL), IL-10 significantly augmented IL-2-induced ATURAL KILLER (NK) cells are large granular lymphocytes (LGL) that are capable of producing large amounts of interferon-y (IFN-y) and demonstrate cytotoxic activity against both tumor cells and virally infected cells without prior sensitization. NK cells may therefore play an important role in the early defense against viral infection and malignant transformation. All human NK cells express the CD56 antigen, an isoform of the neural cell adhesion molecule whose function on LGL remains unknown. In addition, most NK cells possess the FcRyIII surface antigen (CD16) that is important in mediating antibody-dependent cellular cytotoxicity. ' Approximately 10% of NK cells have high-density expression of CD56 (CD56b"gh') on their surface. CD56'nEh' NK cells constitutively express the high-affinity heterotrimeric interleukin-2 receptor (IL-2R), as well as the intermediateaffinity heterodimeric IL-2R.2~3 The more abundant CD56d'"' NK cells constitutively express only the intermediate-affinity heterodimeric IL-2R." The binding of IL-2 to the high-affinity IL-2R expressed on CD56'"sh' NK cells results in a strong proliferative signal, whereas complete saturation of the intermediate-affinity IL-2R on either CD56b"gh' or CD5@" NK cells results in enhanced cytotoxic activity with little or no effect on proliferation. Thus, the high-and intermediateaffinity IL-2R appear to mediate distinct functional responses after the binding of IL-2.'.3,s Human IL-10 is an 18-kD polypeptide that lacks detectable glycosylation and is expressed as a noncovalent homodimer.6 IL-10 was originally identified as a secretory product of T-helper 2 (Th2) cells that inhibited the production of IL-2 and IFN-y by T-helper 1 (Thl) cells via its ability to impede many aspects of macrophage acti~ation.~.~ Likewise, IL-l0 can inhibit monocyte-induced NK cell production of IFN-y through a similar mechanism.'0,'' Interestingly, human IL-IO exhibits 71% sequence homology to a previously uncharacterized open reading frame in the Epstein-Barr virus genome known as BCRF-l. The BCRF-1 protein mimics the proliferation of the CD56b"ght NK cell subset mediated via the high-affinity IL-2R. In the absence of iL-2, IL-10 was able t o induce significant NK cytotoxic activity against NK-resistant tumor cell targets in both subsets of NK cells in a dosedependent fashion. Furthermore, the combination Of !L-10 and IL-2 had an additive effect on NK cytotoxic activity. whereas that of IL-10 and IL-12 did not. Production of interferon-y, tumor necrosis factor-a, and granulocyte-macrophage colony-stimulating factor by IL-2-activated NK cells was also significantly enhanced by IL-10. Neither resting nor activated human NK cells appear t o produce human IL-10 protein. In summary, NK cells constitutively express the IL-10R protein in low density, and the functional consequences of IL-10 binding directly t o human NK cell subsets appear t o be stimulatory and dose-dependent. In contrast to its direct effects on human T cells and monocyteslmacrophages, IL- activity of IL-10 in vitro and may be important in modulating the interaction of the virus with the host immune system.'""
Recent studies have shown that T cells express the ILIORi4 and that IL-10 can directly inhibit T-cell proliferation and IL-2 production after stimulation with immobilized OKT3 monoclonal antibody (MoAb).'' Human NK cells also express the IL-1OR tran~cript.'~ However, the direct effects of IL-10 on human NK cells have yet to be fully investigated. In the present report, we further characterize IL-1 OR expression on human NK cells and analyze the functional consequences of IL-10 binding to purified populations of NK cells.
MATERIALS AND METHODS
Cytokines. All cytokines used in this study were purified recombinant proteins of human origin. IL-10 was provided by ScheringPlough Research Institute (Kenilworth, NJ; specific activity, 11 X lo6 IRUhg). IL-2 was obtained from Hofmann LaRoche (Nutley, NJ; specific activity, 1.53 X lo7 U/mg). Tumor necrosis factor-a (TNF-a; specific activity, 2 X 10' Ulpg) was obtained from the Asahi Chemical Corp (Fuji City, Japan). IL-I 2 (specific activity, 4.5 X 10' U/mg) was obtained from Genetics Institute (Cambridge, MA). AI1 cytokines were reconstituted in RPMI-I640 supplemented E). Fluorescein isothiocyanate (F1TC)-labeled MoAbs to CD2, CDlla (LFA-I), CD25 (IL-2Ra), CD54 (ICAMl), and CD58 (LFA-3) were purchased from Becton Dickinson (San Jose, CA). CD122 (IL-2RP) was purchased from Endogen (Boston, MA). Anti- Tac MoAb (anti-CD25 or anti-IL-2Ra) sterile mouse ascites was a generous gift of Dr Kendall Smith (Cornell Medical School, New York, NY)." Antibody was purified from ascites using the Affi-gel protein A MoAb purification system (Bio-Rad Laboratories, Richmond, CA) in accordance with the manufacturer's instructions.
Cell in RPMI-I640 supplemented with 10% human AB serum (HAB; C-Six Diagnostics, Mequon, WI), and adhered to plastic for 2 hours. T cells, B cells, and remaining monocytes were depleted using goat antimouse immunomagnetic beads (Advanced Magnetics, Cambridge, MA) and a combination of murine MoAbs reactive against CD3, CD4, and HLA-DR, as previously described." For the purpose of the proliferation and cytotoxicity assays, nondepleted cells were then stained with CD56-PE, washed in 10% HAB, and sorted for CD56h"gh' and CD56"m NK cells on a FACStar Plus (Becton Dickinson, Mountan View, CA) as previously described.* Sorted CD56+ NK cells were always 2 9 7 % pure by FACStar analysis. For the purposes of the Northern analyses and the radiolabeled IL-IO binding experiments, fresh cells were adhered and depleted with immunomagnetic beads as described above and then labeled again with a combination of anti-CD3, CD4, CDIY, and CD33 mouse IgG, MoAbs (Miltenyi Biotec, Sunnyvale, CA), washed twice, labeled with colloidal superparamagnetic microbeads recognizing the mouse MoAbs (Miltenyi Biotec), and passed over a magnetic cell sorting (MACS) column (Miltenyi Biotec). The nonadherent cell fraction consistently demonstrated a purity of CD3-CD56' cells between 94% and 97% when an ungated fraction of cells was analyzed on a FACScan.
Proliferation assays. Sorted CD56b"sh' or CD56"'" NK cells (2 "Chromium release cytotoxicity msuy. Sorted CD5hh'"'h' or CD56d'm NK cells were plated in 96-well V-bottom plates (Costar. Cambridge, MA) in 200 pL of RPMI-I 640 media supplemented with 10% HAB with or without cytokines. After I8 hours of incubation at 37"C, 4 X 10351Cr-labeled COLO 205 tumor cell targets were added to each well. Plates were centrifuged for 3 minutes at 800 RPM and incubated for an additional 4 hours at 37°C. Plates were then centrifuged and the supernatant from each well was harvested using a filter harvesting system (Skatron, Sterline, VA). Minimum and maximum "Cr release were determined in 10% HAB and 1 % NP-40 detergent, respectively. Specific lysis was determined as previously described.'* NK cell cytokine producrion. Sorted CD56 NK cells ( I X I o j ) were resuspended in RPMI-I640 with 10% HAB and antibiotics and plated in the presence or absence of cytokines in 96-well U-bottom plates in a total volume of 200 p L per well. Cells were incubated at 37°C for 72 hours, after which supernatants were harvested, aliquoted, and frozen at -70°C. At a later date, culture supernatants were thawed at 37OC in a water bath and assayed by enzyme-linked immunosorbent assay (ELISA) for production of human TNF-a. granulocyte-macrophage colony-stimulating factor (GM-CSF; Quantikine; R & D Systems, Minneapolis, MN), IFN-y (GIBCO BRL, Gaithersburg, MD), and IL-l0 (Biosource International, Camarillo, CA).
Northern analysis for human IL-IOR transcript. RNA was isolated from highly purified (294%) resting and IL-2-activated NK cells and control cell lines using RNAzol (Tel-Test Inc. Friendswood, TX), as per the manufacturer's recommendations.'" IL-2 activation of NK cells was achieved by 72 hours of culture in media containing 10% HAB and 1 nmol/L IL-2 (-230 U/mL). RNA from Ba8. I and Ba/F3Neo served as positive and negative controls for human IL-IOR transcripts, re~pective1y.I~ The L7 cDNA is a constitutively expressed mammalian ribosomal protein that was used as a control for RNA loading.*" RNA was capillary transferred to Zeta Probe GT nylon membranes (Bio-Rad, Hercules, CA), transilluminated, and prehybridized following the manufacturer's specifications. Blots were then hybridized with a '*P dCTP (Pharmacia, Piscataway, NJ) random-labeled full-length cDNA prohe for human IL-1OR (pSW8.I clone, kindly provided by Dr Kevin Moore, DNAX Research, Palo Alto, CA).I4 After two washes, hybridized membranes were exposed to Kodak X-OMAT AR film (Kodak, Rochester. NY) at -70°C. Quantitative measurements of IL-IOR hybridization signals were made on an Apple Onescanner (Apple Computer, Cupertino, CA) with reference to the L7 hybridization signal as a standard. For the purposes of comparison, background was subtracted from the IL-IOR and L7 signals and the ratio of their intensities was calculated using Scan Analysis software (Biosoft. Ferguson. MO).
Anulysis oflL-l0 binding to resting NK cell.\. Resting NK cells were isolated from fresh leukopacs using immunomagnetic bead depletion and then applied to an MACS column as described above, with identical cell purity. After resuspension, cells were tested for specific binding using '251-labeled human recombinant L 1 0 ('"l-IL-IO) as described." Briefly, 5 x 10' cells were pelleted by centrif- (Fig 1A through C) .
Binding of radiolabeled IL-IO to human NK cells. To determine if human NK cells were in fact expressing a protein receptor specific for human IL-10, highly purified (294%) NK cells were incubated with '251-IL-10 in the presence or absence of a 1,000-fold molar excess of unlabeled human IL-IO. Both resting and IL-2-activated NK cells were tested in this assay. As shown in Fig 2A, radiolabeled IL-10 binds to resting NK cells with a significant degree of specificity. This level of specific IL-10 binding is comparable to that seen in IL-10-responsive cell types that we have previously tested." However, despite the reduction in IL-1OR transcript found when human NK cells are cultured for 72 hours in l n m o n IL-2 (Fig l) , there does not appear to be a significant decrease in IL-1OR surface protein expression in IL-2-activated NK cells as measured by the specific binding of radiolabeled ligand (Fig 2A) .
To further characterize IL-1OR protein expression on resting human NK cells, we sought to determine the binding affinity and estimate the number of binding sites or receptors per cell. A typical saturation binding curve with freshly isolated highly purified resting human NK cells is shown in Fig 2B. IL-10 alone did not support the survival of CD56b"gh' NK cells, as shown by vital dye exclusion (data not shown). We next tested the proliferation of CD56b"Sh' NK cells in response to varying concentrations of IL-10 in the presence or absence of 1.5 ng/mL IL-2 (100 pmol/L). As seen in Fig 3, IL-l0 alone did not induce proliferation of CDS6'"gh' NK cells at any concentration. CD56h"ght NK cells constitutively express a high-affinity IL-2R that mediates a brisk proliferative response in the presence of picomolar concentrations of IL-2.2.3 The proliferation of CD56brigh' NK cells in response to 1.5 ng/mL (100 pmol/L) IL-2 was potentiated by the addition of IL-10 beginning at IL-10 concentrations of 0.05 ng/mL, with a peak 60% increase over baseline occurring at 0.5 ngImL. At higher concentrations of IL-10, a progressive diminution in CD56brigh' proliferation was seen. At 50 nglmL of IL-10, IL-2-induced ['HIthymidine uptake was no longer augmented by IL-10. When cell enumeration in vital dye was performed in parallel experiments, changes in NK cell number did correlate with the increases in t3H]thymidine incorporation seen under the various experimental conditions described above. However, the absolute number of CD56'ngh' NK cells did not increase drastically, likely because of the fact that a significant fraction of this population is not responsive to IL-2 and consequently undergoes cell death."
As shown in Fig 4A, 0 .5 ng/mL of IL-10 potentiated the IL-2-induced proliferation of CD56b"8h' NK cells over a limited range of IL-2 concentrations. IL-10 caused a shift in the IL-2 dose-response curve at IL-2 concentrations that partially saturate the high-affinity IL-2R, ranging from 0.015 to 1.5 ng/mL (I to 100 pmo1L). However, at an IL-2 concentration of 15 ng/mL (1 n m o n ) , the high-affinity IL-2R remains completely saturated for the 96-hour incubation period, and partial saturation of the intermediate affinity IL-2R also occurs?.3 At this point of maximal IL-2-induced proliferation, IL-10 is no longer able to potentiate the proliferative response to IL-2.
The CD56di" NK cell population expresses only the intermediate-affinity IL-2R that provides a relatively weak proliferative signal when activated with nanomolar concentrations of IL-2.' By itself, 0.5 ng/mL IL-10 did not induce CD56di" NK cell proliferation (data not shown). IL-2-induced proliferation mediated via the intermediate-affinity IL-2R was only minimally enhanced by IL-10 (0.5 ng/mL), and the overall response remained weak relative to CD56b"Sh' NK cells (Fig 4B) .
To determine if IL-10 was potentiating IL-2-induced proliferation mediated via the high-affinity IL-2R, we stimulated CDS6b"gh' NK cells with both IL-2 (0.3 ng/mL or 20 pmoll L) and IL-10 (0.5 ng/mL) in the presence or absence of anti-Tac (anti-CD25) MoAb. Anti-Tac MoAb abrogates the CD56b"gh' NK cell proliferative response mediated via the high-affinity IL-2R by blocking the binding of It-2 to the IL-2Ra (p55) protein subunit of the heterotrimeric receptor complex.2,' As can be seen in Fig 5 , tumor cell targets when incubated overnight in medium containing SO ng/mL of IL-IO compared with incubation in medium alone. This effect of IL-IO alone seemed to be more pronounced in CDS6hr'sh' NK cells. A dose-response curve measuring NK cytotoxic activity against NK-resistant tumor cell targets in a sorted population of CDS6""" N K cells illustrates that the enhanced cytotoxic effect is most pronounced at high concentrations ( S to SO ng/mL) of IL-IO (Fig 6R) . Culture of CDS6'1"" N K cells in SO ng/mL IL-IO resulted in 22% killing against COLO 205 versus 4% when incubated in media alone ( P < .OS).
Greater enhancement of CDS6'""' N K cell cytotoxicity could be achieved by the incubation of effectors in medium plus 15 ng/mL ( 1 nmol/L) of IL-2, which resulted in 40% cytotoxicity against COLO 205. The combination of IL-2 and IL-IO had an additive effect on NK cytotoxic activity such that incubation of CDS6'"" NK effectors in 15 ng/mL IL-2 plus 50 ng/mL 1L-IO resulted in 75% lysis of COL0 205 (Fig 6C) . A similar additive effect was not apparent with the CD56h"S'" NK cells, possibly because of the dramatic increase in cytotoxic activity seen with IL-IO alone (see above).
In similar cytotoxicity experiments using CDS6""" NK errectors and L 1 2 as an NK cell stimulatory cytokine, IL-IO had no effect on IL-12-induced NK cc11 cytotoxicity. Antibody-dependent cell cytotoxicity was not potentiated by IL-I O either alone or in combination with IL-2 or IL-12 (data not shown).
Cellular adhesion molecules (CAM) are critical to the formation of conjugates betwccn NK effectors and their targets and are responsible at least in part for the development of IL-2-induced cytotoxic activity.lx Having determined that IL-l0 alone could induce significant NK cell cytolytic activity and potentiate IL-2-induced cytotoxicity against NK-resistant targets, the effects of IL-l0 on NK cell CAM expression were examined. Sorted CDS6+ NK cells were cultured for up to 72 hours in media alone (negative control), 15 ng/mL IL-2 alone (positive control), S 0 ng/mL IL-10, or 15 ng/mL 1L-2 in combination with 50 ng/mL IL-10 and then analyzed for cell surface expression of CD2, CD1 la, CD54, CDS6, and CD58 via flow cytometry. In contrast to IL-2 alone, IL-I O had no significant effect on NK cell CAM expression, either alone or in combination with 1L-2. Additional studies showed that incubation of human NK cells in the presence of 50 ng/mL IL-I0 or in combination with IL-2 did not significantly alter the cell surface expression of IL-2Ra or IL-2RP (data not shown).
Effect oflL 10 on NK cell cytokine production. NK cells have bcen shown to produce GM-CSF, TNF-a, and IFN-y after stimulation with monocyte-derived factors such as TNF-a and IL-12, both alone or in combination with ILIndeed, the ability of IL-10 to supprcss NK cell IFNy production occurs indirectly via suppression of monocyte/ 2.2427 CARSON ET AL macrophage cytokine production."'." In the present study, we assessed the direct effects of IL-10 on NK cell cytokine production. Highly purified populations of CD%+ NK cells were sorted from fresh blood and cultured for 72 hours with IL-2 and/or 1L-12, either alone or in combination with IL-10. At the end of the incubation period, NK cell culture supernatants were assayed for the production of IFN-y, TNFa , or GM-CSF. Two observations were made (Fig 7A  through C) . First, IL-IO alone did not have any stimulatory effect on NK cell cytokine production. Secondly, IL-l0 consistently enhanced the NK cell production of IFN-y, TNFa , and GM-CSF in the presence of IL-2 but not of 1L-12. The augmentation of cytokine production after 72 hours of incubation in IL-IO plus IL-2 appeared to result from an increase in the endogenous production of cytokine, because there was no relative or absolute increase in NK cell numbers cultured under these conditions when compared with cells cultured in IL-2 alone.
In similar experiments we tested sorted CD56d'" NK cells for their ability to produce IL-10. Using an ELISA with a sensitivity of 40 pg/mL, we were unable to detect human TL-10 production from resting NK cells, nor could this activity be induced after 72 hours of culture of NK cells in IL-2, 1L-12, or TNF-a either alone or in combination (data not shown).
DISCUSSION
In the present study, we have characterized IL-1 OR expression and the functional consequences of L 1 0 binding directly to human NK cells. Using highly purified populations of human NK cells, we have shown that human IL-l0 can directly induce NK cytotoxic activity against tumor-resistant targets as well as augment IL-2-induced proliferation, cytotoxicity, and cytokine production. Antigen-presenting cells The binding experiments performed with scrial dilutions of '2'I-IL-10 on resting human NK cells in the presence and absence of excess unlabeled 1L-l0 confirmed the estimate of a low number (-90) of IL-l OR siteskell and also provided information about thc kd (-I nmol/L) of this receptor. Furthermore, the repeat binding studies performed on human NK cells that had been activated in the presence of IL-2 for 72 hours suggested that, unlike the IL-IOR transcript, the number of surface IL-IOR protein sites does not change significantly under conditions oflL-2 activation. This finding is consistent with our observation that both IL-IO and IL-2 appear to have similar and at times additive stimulatory effects on human NK cells.
In some respects, the functional consequences of human &l0 binding to CD56h""l" N K cells are similar to those that we recently reported for the ligand to the tyrosine kinase receptor c-kit.'" Alone, c-kit ligand (KL) had no effect on proliferation of CDS6h"sh' NK cells. However, KL was able to significantly augment the proliferative effect of IL-2, causing a marked shift iu the dose-response curve at TL-2 conccntrations that selectively saturate the high-affinity IL-2R.I" Similarly, IL-10 by itself had no effect on CDS6h"s'" N K cell proliferation but was able to potentiate IL-2-induced proliferation mediated by the binding of TL-2 to the high- For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
